PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2010 | 63 |
| 2011 | 55 |
| 2012 | 57 |
| 2013 | 85 |
| 2014 | 78 |
| 2015 | 78 |
| 2016 | 62 |
| 2017 | 97 |
| 2018 | 70 |
| 2019 | 70 |
| 2020 | 97 |
| 2021 | 114 |
| 2022 | 104 |
| 2023 | 101 |
| 2024 | 116 |
| 2025 | 134 |
| 2026 | 134 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Eur Respir Rev"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
The prognostic value of physical functioning on survival in patients with nonsmall cell lung cancer: a systematic review and meta-analysis.
- Arents E, Haesevoets S, Van Overbeke M, Quadflieg K, Van Hulle F, Salhi B, Criel M, Stevens D, Ruttens D, Surmont V, Daenen M, Derom E, Burtin C, Demeyer H.
- Eur Respir Rev. 2026 Oct 21;35(182):250230. doi: 10.1183/16000617.0230-2025.
- PMCID: PMC13684416
Arents E, et al.Eur Respir Rev. 2026.PMCID: PMC13684416 -
Haemoptysis in chronic pulmonary vascular disease: a narrative review.
- Kamp JC, Budhram B, Jevnikar M, Olsson KM, Peperhove MJ, Neubert L, Hoeper MM, Humbert M.
- Eur Respir Rev. 2026 Oct 21;35(182):260055. doi: 10.1183/16000617.0055-2026.
- PMCID: PMC13684417
Kamp JC, et al.Eur Respir Rev. 2026.PMCID: PMC13684417 -
Geriatric respiratory medicine 2026: from artificial intelligence to personalised management of the multimorbid patient.
- Sorino C, Cameli P, Canonica GW, Carpagnano GE, Cortegiani A, Costantino C, Di Bona D, Malerba M, Maresca A, Pelaia C, Principe S, Ragnoli B, Rogliani P, Scarlata S, Tomasello A, Tramonte L, Tuttolomondo A, Vatrella A, Vitulo P, Zito A, Scichilone N.
- Eur Respir Rev. 2026 Oct 21;35(182):260115. doi: 10.1183/16000617.0115-2026.
- PMCID: PMC13684414
Sorino C, et al.Eur Respir Rev. 2026.PMCID: PMC13684414 -
Carcinoids of the lung caused by exogenous noxious agents: a scoping review.
- Kilo S, Schröder C, Frei-Stuber L, Jöckel KH, Jonigk D, Länger F, Nowak D.
- Eur Respir Rev. 2026 Oct 21;35(182):260145. doi: 10.1183/16000617.0145-2026.
- PMCID: PMC13684415
Kilo S, et al.Eur Respir Rev. 2026.PMCID: PMC13684415 -
Interventions to increase participation in lung cancer screening programmes: a systematic review and meta-analysis.
- Djuric O, Guida A, Bononi F, Venturelli F, Bassi MC, Gorini G, Paci E, Mantellini P, Giorgi Rossi P.
- Eur Respir Rev. 2026 Oct 21;35(182):260108. doi: 10.1183/16000617.0108-2026.
- PMCID: PMC13684418
Djuric O, et al.Eur Respir Rev. 2026.PMCID: PMC13684418 -
The dipeptidyl peptidase 1 inhibition landscape in bronchiectasis and its future direction.
- Chalmers JD, Jain R, O'Donnell AE, Mall MA, Flume PA.
- Eur Respir Rev. 2026 Oct 7;35(182):260213. doi: 10.1183/16000617.0213-2026.
- PMCID: PMC13643495
Chalmers JD, et al.Eur Respir Rev. 2026.PMCID: PMC13643495 -
Manual compared to automated closed-loop oxygen control strategies in hospitalised adults: a systematic review and meta-analysis.
- Kirton L, Biggs R, Kivi N, Lynch F, Kingi T, Sayers R, Sparks J, Eathorne A, Weatherall M, Beasley R.
- Eur Respir Rev. 2026 Oct 7;35(182):260167. doi: 10.1183/16000617.0167-2026.
- PMCID: PMC13643497
Kirton L, et al.Eur Respir Rev. 2026.PMCID: PMC13643497 -
Inflammasomes in respiratory diseases: from disease pathogenesis to drug development and use of multi-omics.
- Shipley R, O'Rourke MB, Idrees S, Vaughan A, Paudel KR, Philp AM, Wadhwa R, Dharwal V, Hortle E, Choi JP, Quan D, Liu G, Faner R, Faiz A, Hansbro PM, Johansen MD.
- Eur Respir Rev. 2026 Oct 7;35(182):260205. doi: 10.1183/16000617.0205-2026.
- PMCID: PMC13643496
Shipley R, et al.Eur Respir Rev. 2026.PMCID: PMC13643496 -
Bridging bench and bedside: translational omics of Pseudomonas aeruginosa to validate physiologically relevant models of chronic respiratory infection in cystic fibrosis.
- Wauters M, Bollé L, Van Braeckel E, Crabbé A.
- Eur Respir Rev. 2026 Oct 7;35(182):250282. doi: 10.1183/16000617.0282-2025.
- PMCID: PMC13643499
Wauters M, et al.Eur Respir Rev. 2026.PMCID: PMC13643499 -
Effects of opioids and stimulants on the respiratory system.
- Lildharrie C, Veenker FN, Miller KB, Yonga MV, Abey S, Wang GJ, Kim SW, Demiral SB, Volkow ND.
- Eur Respir Rev. 2026 Oct 7;35(182):260092. doi: 10.1183/16000617.0092-2026.
- PMCID: PMC13643504
Lildharrie C, et al.Eur Respir Rev. 2026.PMCID: PMC13643504